← All stocks

Protalix BioTherapeutics, Inc.

PLX No buying or selling
CIK 0001006281 #3972 in the set updated 19 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

10 insiders · 0 transactions
11.4×

Dror Bashan holds 11.4 times base salary in stock. $4.58M of shares against $401.84K in salary for 2025.

Salary from the company's own proxy. The shares are what Dror Bashan last reported holding, valued at $1.81, the price Common Stock was last bought or sold at on the open market here, on 19 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Bashan Dror
PRESIDENT AND CEO
2,532,934
$4.58M
+11.0%
Rubin Eyal
Sr. VP and CFO
669,010
$1.21M
+17.4%
Schwartz Aharon
Director
310,500
$562.01K
+78.4%
Naos Yaron
Sr. VP & COO
225,817
$408.73K
+12.4%
Forster Eliot
Director
7,500
$13.58K
Bar-Shalev Amos
Director
7,500
$13.58K
+4,364%
Melincoff Gwen A
Director
7,500
$13.58K
Boudes Pol F
Director
7,500
$13.58K
Elze Christian
Director
7,500
$13.58K
Ben Zvi Shmuel
Director
7,500
$13.58K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 9
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 16 Sep 2016